$2.29
Acurx Pharmaceuticals is a biotechnology business based in the US. Acurx Pharmaceuticals shares (ACXP) are listed on the NASDAQ and all prices are listed in US Dollars. Acurx Pharmaceuticals employs 4 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Acurx Pharmaceuticals LLC stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- No-cost financial planning and automated investing
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
How to buy Acurx Pharmaceuticals stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ACXP. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Acurx Pharmaceuticals stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Acurx Pharmaceuticals stock price (NASDAQ: ACXP)
Use our graph to track the performance of ACXP stocks over time.Acurx Pharmaceuticals shares at a glance
Latest market close | $2.29 |
---|---|
52-week range | $1.17 - $8.82 |
50-day moving average | $2.33 |
200-day moving average | $3.02 |
Wall St. target price | $11.66 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.18 |
Is it a good time to buy Acurx Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Acurx Pharmaceuticals price performance over time
Historical closes compared with the close of $2.29 from 2024-07-23
1 week (2024-07-17) | -12.60% |
---|---|
1 month (2024-06-24) | 0.44% |
3 months (2024-04-24) | 12.81% |
6 months (2024-01-24) | -43.03% |
1 year (2023-07-24) | 11.71% |
---|---|
2 years (2022-07-22) | -36.57% |
3 years (2021-07-23) | 5.57 |
5 years (2019-07-20) | N/A |
Acurx Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -121.65% |
Return on equity TTM | -283.87% |
Profit margin | 0% |
Book value | $0.38 |
Market Capitalization | $38.5 million |
TTM: trailing 12 months
Acurx Pharmaceuticals share dividends
We're not expecting Acurx Pharmaceuticals to pay a dividend over the next 12 months.
You may also wish to consider:
- Pfizer (PFE.US) (5.65% forward annual dividend yield)
- Novartis AG ADR (NVS.US) (3.38% forward annual dividend yield)
- Merck-and-Company (MRK.US) (2.48% forward annual dividend yield)
Acurx Pharmaceuticals share price volatility
Over the last 12 months, Acurx Pharmaceuticals's shares have ranged in value from as little as $1.17 up to $8.82. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Acurx Pharmaceuticals's is -1.719. This would suggest that Acurx Pharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Acurx Pharmaceuticals has bucked the trend.
To put Acurx Pharmaceuticals's beta into context you can compare it against those of similar companies.
- Pfizer (PFE.US): 0.634
- Novartis AG ADR (NVS.US): 0.491
- Merck-and-Company (MRK.US): 0.389
Acurx Pharmaceuticals overview
Acurx Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York. .
Frequently asked questions
nullWhat percentage of Acurx Pharmaceuticals is owned by insiders or institutions?
Currently 15.178% of Acurx Pharmaceuticals shares are held by insiders and 12.532% by institutions. How many people work for Acurx Pharmaceuticals?
Latest data suggests 4 work at Acurx Pharmaceuticals. When does the fiscal year end for Acurx Pharmaceuticals?
Acurx Pharmaceuticals's fiscal year ends in December. Where is Acurx Pharmaceuticals based?
Acurx Pharmaceuticals's address is: 259 Liberty Avenue, Staten Island, NY, United States, 10305 What is Acurx Pharmaceuticals's ISIN number?
Acurx Pharmaceuticals's international securities identification number is: US00510M1045
More guides on Finder
-
Opto review 2024: $0 commission, fractional theme investing
Trade commission-free stocks and ETFs with Opto, and stay ahead by spotting emerging trends through thematic investing.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
How to buy the new spot Ethereum ETFs
Spot Ethereum ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
-
Best broker cash sweep rates for July 2024
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 best day trading platforms of July 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 top semiconductor stocks to buy in 2024
We’ve rounded up stats on some of the most popular semiconductor stocks, along with information on how they compare and how to invest.
-
11 best brokerage accounts of July 2024: Top picks for investors
Check out our picks of the best brokerage accounts for beginners, micro-investing, crypto trading and more.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
7 best ways to invest $10K
Check out our 7 ideas for how to invest $10K to maximize your money.
Ask a question